Mon, Mar 21, 2022
The company said the PAS it has received is for site transfer into Jarod.
More >
Mon, Dec 13, 2021
Drug firm Zydus Cadila on Monday said it has received approval to commence Phase II clinical study of its upcoming product with patients suffering with Cryopyrin-Associated Periodic Syndrome (CAPS) in Australia.
Thu, Dec 02, 2021
Zydus Cadila's COVID-19 vaccine ZyCoV-D will initially be used in seven states, including Maharashtra, Tamil Nadu, Uttar Pradesh and West Bengal, which have been recommended to identify the districts with a high number of of beneficiaries who have not received a single dose of a Covid vaccine for its introduction.
Sat, Nov 20, 2021
The company has received final approval from the US Food and Drug Administration (USFDA) to Decitabine for Injection in the strength of 50 mg/vial single-dose vial, Zydus Cadila said in a statement
Sun, Oct 31, 2021
Zydus Cadila has agreed to bring down the price of its COVID-19 vaccine to Rs 265 a dose following persistent negotiations by the government but a final deal is yet to be reached, sources said on Sunday.
Fri, Oct 29, 2021
Drug firm Cadila Healthcare on Monday reported an over six-fold jump in its consolidated net profit to Rs 3,002.3 crore for the quarter ended September 30, 2021
Sat, Aug 21, 2021
Zydus Cadila ZyCoV-D vaccine: The vaccine will be administered in 3-dose and work on even Children and adults of age 12 years and above.
Covid 19 new vaccine: The world’s first and India’s indigenously developed DNA based vaccine for COVID-19 will be administered in 3-dose.
Mon, Aug 09, 2021
After Johnson and Johnson single dose COVID-19 vaccine, Zydus vaccine may get the approval for use in India by this week
Tue, Sep 22, 2020
As the world waits expectantly for COVID-19 vaccine, Zydus Cadila Chairman Pankaj R Patel said India would need to invest between Rs 3,000-5,000 crore to create additional facilities for making a huge number of vaccines required for the Indian population
Fri, Jul 03, 2020
The potential vaccine showed a "strong immune response" in animal studies, and the antibodies produced were able to completely neutralize the wild type virus, Zydus, part of Cadila Healthcare Ltd, said in a statement to Indian stock exchanges.
Sat, May 02, 2020
Drug firm Zydus Cadila on Saturday said it has received tentative nod from the US health regulator to market generic Empagliflozin and Metformin Hydrochloride tablets, used for management of type-2 diabetes, in the American market.
Sat, Apr 06, 2019
Tofacitinib is used alone or with other medications to treat moderate to severe forms of rheumatoid arthritis, the company said in a BSE filing.
Wed, Mar 13, 2019
The company has more than 254 approvals and has so far filed over 350 abbreviated new drug applications (ANDAs) since it commenced filings in 2003-04.
Mon, Dec 31, 2018
Bank Nifty opened in the green at Rs 27,260, up by 135 points. Crude was stable and closed at $52.25 per barrel on Friday. Indian rupee appreciated by 14 paise to Rs 69.8 per dollar.
Wed, Dec 12, 2018
Shares of Zydus Wellness surged over 4 per cent Wednesday as the CCI approved Zydus Cadila's deal to acquire Heinz India's consumer wellness business.
Fri, Nov 16, 2018
Drug firm Zydus Cadila Friday said it has received final approval from the US health regulator to market generic Abacavir and Lamivudine tablets used for treatment of a type of HIV infection.
Sat, Jul 08, 2017
The group now has more than 120 approvals and has so far filed over 300 abbreviated new drug applications (ANDAs), it added.
Tue, Mar 07, 2017
NPPA on Tuesday tweeted list of 23 essential medicines under NLEM 2015 of which prices were reduced for more than 50% from March to October 2016.
Wed, Dec 28, 2016
Though the companies have not disclosed the financial details of the deal.
Zee Business brings you the most important stories of the day that will help you shape your market strategies and keep you informed with the latest developments.
Sat, Dec 03, 2016
Drug firm Zydus Cadila on Saturday said the patent litigation relating to Allergan's Delzicol, used to treat ulcerative colitis, has been settled. The patent litigation relating to Allergan's Delzicol (mesalamine) has been settled, Zydus Cadila said in a statement.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
